Resistance Patterns and Genetic Variations in Patients With Hepatitis C Virus: Emerging Role of Telaprevir

Virus Adaptation and Treatment - New Zealand
doi 10.2147/vaat.s7209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effect of Fibrosis on Adverse Events in Patients With Hepatitis C Treated With Telaprevir

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2013English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Prediction of Treatment Efficacy and Telaprevir-Resistant Variants After Triple Therapy in Patients Infected With Hepatitis C Virus Genotype 1

Journal of Clinical Microbiology
Microbiology
2013English

Inflammatory Patterns in Patients With Chronic Hepatitis C

BMC Infectious Diseases
Infectious Diseases
2013English

Telaprevir in a Patient With Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

New Agents for the Treatment of Hepatitis C Virus &Ndash; Focus on Telaprevir

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2012English

Genetic Diversity of Hepatitis B Virus and Hepatitis C Virus in Human Immunodeficiency Virus Type 1-Co-Infected Patients From Venezuela

Journal of Medical Microbiology
MedicineMicrobiology
2014English

The Distribution of Hepatitis C Virus Genotypes in Patients With Chronic Hepatitis C Infection

Türk Mikrobiyoloji Cemiyeti Dergisi
2016English

CPC-107 Pharmacotherapy Follow-Up in Chronic Hepatitis C Patients Treated With Boceprevir or Telaprevir

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy